miR-15 and miR-16 were raised as potential therapeutic targets, as their restoration in expression promoted cell death, partly through the down-regulation of CCND1 (Cyclin D1) in metastatic rat pheochromocytoma cells [72]. The gene discussed is CCND1; the disease is hereditary pheochromocytoma-paraganglioma.